BsAb-5

N/A

Report date: 2023/02/06 10:52:33

Base Information

Drug NameBsAb-5

Drug Alias NameBsAb-5

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Hepatocyte growth factor receptorAnti-CTLA4

TargetsHepatocyte growth factor receptorCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesThe First Affiliated Hospital Of Guangzhou Medical University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Guangzhou Medical University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A